Latest Executive Management News

PYC Therapeutics has restructured its Board and executive team to steer the company through pivotal clinical milestones expected by the end of 2027. The changes signal a strategic push toward late-stage development of its RNA-based drug candidates.

Aspermont Limited invites existing shareholders to participate in a $1.25 million Share Purchase Plan at a premium price, supporting its pivot to data-driven intelligence services and a strategic Rio Tinto partnership.

Hubify Limited has turned the corner with a statutory loss narrowing to $813,909 in FY25, alongside a 108% surge in EBITDA and a robust cash position. The company’s strategic pivot to recurring managed and professional services underpins its renewed financial health.

Altamin Limited announces a significant board and executive reshuffle, appointing Peter Edwards as non-executive Chairman and Geraint Harris as incoming CEO, signaling a renewed focus on critical raw materials for Europe’s energy transition.

Vysarn Limited reported a robust 40% increase in revenue to $106.5 million for FY2025, driven by key acquisitions and national expansion. The company’s profit after tax rose 34%, underscoring its growing footprint in Australia’s water infrastructure sector.

Iress Limited reported a robust first half of 2025 with strong earnings growth and reduced leverage, driven by core business strength and strategic divestments. The company is poised to capitalize on regulatory tailwinds and technology demand in wealth and trading sectors.

Winchester Energy has appointed Jason Peterson and David Wheeler as non-executive directors, restoring its board to the required three members and addressing recent regulatory notices.

Raptis Group Limited completed a nearly $2 million capital raise and announced plans to acquire a related party management business, alongside significant board changes and steady cash flow from its property management operations.

GenusPlus Group has secured a significant maintenance and upgrade contract with Western Power, expected to generate around $65 million in revenue for FY2026, reinforcing its role in Western Australia's electricity infrastructure.

CLINUVEL Pharmaceuticals announces the full-time return of Managing Director Dr Philippe Wolgen, focusing on advancing critical product development and corporate initiatives, while Acting CEO Lachlan Hay continues until September 2025.

Etherstack has landed a $1 million contract to supply digital radio network equipment to the world’s largest iron ore producer in Western Australia, reinforcing its growth in recurring revenues. The company also reports record cash receipts in the first half of 2025, signaling strong momentum.

Genetic Technologies Limited has announced significant leadership changes, appointing Michael Walker as Executive Chairman and Managing Director, alongside new executive and board members.